(Q47356431)

English

Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine

scientific article published in June 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

influenza vaccine

0 references

author name string

Evgenia Greenbaum

1

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Dan Engelhard

2

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Reuven Levy

3

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Miriam Schlezinger

4

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Avraham Morag

5

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Zichria Zakay-Rones

6

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

22

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

20

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

2566-2577

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Enteric immunization of mice against influenza with recombinant vaccinia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Developments in mucosal influenza virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Secretory antibody following oral influenza immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Immunostimulating reconstituted influenza virosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Liposomes and ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Recommendations for the use of inactivated influenza vaccines and other preventive measures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Mucosal [SIgA] and serum [IgG] immunologic responses in the community after a single intra-nasal immunization with a new inactivated trivalent influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

A double-blind trial of a new inactivated, trivalent, intra-nasal anti-influenza vaccine in general practice: relationship between immunogenicity and respiratory morbidity over the winter of 1997-98.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Antibody response to influenza immunization in patients after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Influenza and the work of the World Health Organization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Age-dependent antibody response in mice and humans following oral influenza immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Cold-attenuated live influenza vaccines, a risk-benefit assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Reduction in mortality associated with influenza vaccine during 1989-90 epidemic.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

The hemagglutination inhibition antibody responses to an inactivated influenza vaccine among healthy adults: with special reference to the prevaccination antibody and its interaction with age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.12.018

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/15193382

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47356431&oldid=2153312320"